Literature DB >> 16216329

Cognitive outcome in adults with moderate disability after pneumococcal meningitis.

Martijn Weisfelt1, Diederik van de Beek, Martine Hoogman, Clara Hardeman, Jan de Gans, Ben Schmand.   

Abstract

OBJECTIVES: To assess cognitive outcome and quality of life in patients with moderate disability after bacterial meningitis as compared to patients with good recovery.
METHODS: Neuropsychological evaluation was performed in 40 adults after pneumococcal meningitis; 20 patients with moderate disability at discharge on the glasgow outcome scale (GOS score 4) and 20 with good recovery (GOS score 5).
RESULTS: Patients with GOS score 4 had similar test results as compared to patients with GOS score 5 for the neuropsychological domains 'intelligence', 'memory' and 'attention and executive functioning'. Patients with GOS score 4 showed less cognitive slowness than patients with GOS score 5. In a linear regression analysis cognitive speed was related to current intelligence, years of education and time since meningitis. Overall performance on the speed composite score correlated significantly with time since meningitis (-0.62; P<0.001). Therefore, difference between both groups may have been related to a longer time between meningitis and testing for GOS four patients (29 vs. 12 months; P<0.001).
CONCLUSIONS: Patients with moderate disability after bacterial meningitis are not at higher risk for neuropsychological abnormalities than patients with good recovery. In addition, cognitive slowness after bacterial meningitis may be reversible in time.

Entities:  

Mesh:

Year:  2005        PMID: 16216329     DOI: 10.1016/j.jinf.2005.08.014

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  10 in total

Review 1.  Dexamethasone in adults with community-acquired bacterial meningitis.

Authors:  Diederik van de Beek; Jan de Gans
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Cognitive outcome in adults after bacterial meningitis.

Authors:  Martine Hoogman; Diederik van de Beek; Martijn Weisfelt; Jan de Gans; Ben Schmand
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-12       Impact factor: 10.154

3.  Time-dependent behavioral recovery after pneumococcal meningitis in rats.

Authors:  Tatiana Barichello; Geruza Z Silva; Jaqueline S Generoso; Geovana D Savi; Cleonice M Michelon; Gustavo Feier; Clarissa M Comim; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2010-06-18       Impact factor: 3.575

4.  Long-term outcomes of pneumococcal meningitis in childhood and adolescence.

Authors:  Deborah Christie; Russell M Viner; Kyle Knox; Pietro G Coen; Han Wang; Haitham El Bashir; Rosa Legood; Bharat C Patel; Robert Booy
Journal:  Eur J Pediatr       Date:  2011-01-19       Impact factor: 3.183

5.  TRAIL limits excessive host immune responses in bacterial meningitis.

Authors:  Olaf Hoffmann; Josef Priller; Timour Prozorovski; Ulf Schulze-Topphoff; Nevena Baeva; Jan D Lunemann; Orhan Aktas; Cordula Mahrhofer; Sarah Stricker; Frauke Zipp; Joerg R Weber
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

6.  Distributed, limbic gray matter atrophy in patients after bacterial meningitis.

Authors:  N K Focke; K Kallenberg; A Mohr; M Djukic; R Nau; H Schmidt
Journal:  AJNR Am J Neuroradiol       Date:  2012-11-29       Impact factor: 3.825

Review 7.  Long-term neuropsychological deficits after central nervous system infections despite adequate therapy.

Authors:  Roland Nau; Holger Schmidt
Journal:  J Neurol       Date:  2007-05       Impact factor: 6.682

8.  Indirect costs of adult pneumococcal disease and the productivity-based rate of return to the 13-valent pneumococcal conjugate vaccine for adults in Turkey.

Authors:  J P Sevilla; Andrew Stawasz; Daria Burnes; Anubhav Agarwal; Basak Hacibedel; Kerem Helvacioglu; Reiko Sato; David E Bloom
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

9.  Individual responsiveness of macrophage migration inhibitory factor predicts long-term cognitive impairment after bacterial meningitis.

Authors:  Anne T Kloek; Mercedes Valls Seron; Ben Schmand; Michael W T Tanck; Arie van der Ende; Matthijs C Brouwer; Diederik van de Beek
Journal:  Acta Neuropathol Commun       Date:  2021-01-06       Impact factor: 7.801

10.  Neuronal Damage and Neuroinflammation, a Bridge Between Bacterial Meningitis and Neurodegenerative Diseases.

Authors:  Kristine Farmen; Miguel Tofiño-Vian; Federico Iovino
Journal:  Front Cell Neurosci       Date:  2021-06-03       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.